02.07 22:08 | MÄRKTE USA/Freundlich - Kräftige Gewinne bei Autoaktien |
02.07 18:14 | MÄRKTE USA/Seitwärts in ruhigem Handel - Tesla auf Sechsmonatshoch |
01.07 22:10 | MÄRKTE USA/Freundlich - Technologieaktien favorisiert |
01.07 18:23 | MÄRKTE USA/Etwas fester - Marktzinsen steigen weiter |
01.07 15:22 | dpa-AFX: Orion Stock Up On FY24 Outlook Upgrade After Opevesostat Deal With Merck |
01.07 14:22 | dpa-AFX: *MERCK AND ORION GRANT GLOBAL RIGHTS FOR OPEVESOSTAT IN PROSTATE CANCER TREATMENT; ORION TO GET $975 MLN PAYMENTS |
01.07 14:20 | dpa-AFX: *MERCK AND ORION GRANT GLOBAL RIGHTS FOR OPEVESOSTAT IN PROSTATE CANCER TREATMENT |
28.06 14:43 | dpa-AFX: Merck: CHMP Recommends Approval Of WINREVAIR In Pulmonary Arterial Hypertension |
28.06 14:23 | dpa-AFX: *MERCK GETS POSITIVE EU CHMP OPINION FOR WINREVAIR IN PULMONARY ARTERIAL HYPERTENSION |
27.06 02:36 | dpa-AFX: Merck : FDA Issues Complete Response Letter For Patritumab Deruxtecan In EGFR-Mutated NSCLC |
26.06 08:00 | dpa-AFX: Merck : USDA Approves NOBIVAC NXT, First RNA-Particle Vaccine For Canine Flu H3N2 |
18.06 14:19 | dpa-AFX: Ligand Says Merck Receives FDA Approval For CAPVAXIVE For Adults |
18.06 14:05 | dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS |
03.06 17:10 | dpa-AFX: Merck Says MRNA-4157-Keytruda Combination Data Shows Improvement In High-Risk Melanoma Patients |
03.06 16:05 | dpa-AFX: *MERCK : MRNA-4157-KEYTRUDA COMBINATION DATA SHOWS SUSTAINED BENEFITS IN HIGH-RISK MELANOMA PATIENTS |
03.06 04:32 | dpa-AFX: Immutep Collaborates With Merck To Evaluate Efti In Combination Therapy For Metastatic NSCLC |
01.06 15:53 | dpa-AFX: Lilly Announces Updated Data From Phase 1/2 Study Of Olomorasib In Advanced Solid Tumors |
30.05 11:56 | dpa-AFX: Biotech Stocks Facing FDA Decision In June 2024 |
29.05 12:57 | dpa-AFX: Merck To Acquire EyeBio; Deal Valued Up To $3 Bln |
29.05 12:51 | dpa-AFX: *MERCK SEES EYEBIO DEAL TO RECORD A CHARGE OF ABOUT $1.3 BLN, OR ABOUT $0.50 PER SHARE |
|